ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Ovarian Tissue

Also known as: Ovarian cortical tissue, Ovarian tissue, Ovarian Tissue

Overview

Ovarian tissue of the female reproductive system consists mainly of ovarian follicles that house oocytes. It plays a crucial role in fertility preservation, especially through techniques like cryopreservation and transplantation (OTT), aimed at restoring fertility for women undergoing medical treatments such as chemotherapy, or those with advanced ovarian age. Ovarian tissue is obtained from the ovaries and can retain viable preantral follicles through freezing methods such as slow freezing and vitrification. Research on ovarian tissue transplantation is extensive, with numerous studies confirming its potential for hormone restoration and fertility outcomes. The quality of the available evidence includes systematic reviews, meta-analyses, and observational studies published in reputable peer-reviewed journals.

Benefits

Evidence suggests significant benefits of ovarian tissue transplantation. Restoration of ovarian function is marked by increased estrogen levels (mean difference: 228.24 pmol/l) and reduced FSH levels (mean difference: 61.8 IU/l). Pregnancy and live birth rates following transplantation are promising, though they vary among studies. Notably, the procedure is especially beneficial for women undergoing cancer treatment and those with premature ovarian insufficiency (POI). Estimates indicate a significant increase in pre-transplant estrogen from 101.6 pmol/l to 522.4 pmol/l post-transplant. The expected time for ovarian function restoration typically ranges from a few months, highlighting the relevance of timing in treatment planning.

How it works

The mechanism of action for ovarian tissue transplantation involves the preservation of preantral follicles within ovarian tissue. Through techniques like vitrification or slow freezing, the viability of these follicles is maintained, allowing them to mature and restore ovarian function upon transplantation. The interaction with the reproductive system aids in the restoration of hormonal balance and fertility. Key processes include the viability maintenance of follicular cells, which are essential for successful ovary function restoration.

Side effects

The overall safety profile of ovarian tissue transplantation is high, but it is not without risks. Common surgical complications include infections, bleeding, and adhesion formation, occurring in over 5% of cases. Less common reactions, occurring in 1-5%, include the rejection of transplanted tissue, while rare (<1%) but serious risks involve possible cancer reseeding if contaminated tissue is used. Screening protocols are in place to mitigate this risk. There are no specific drug interactions associated with the tissue itself, although medications used during or after the procedure may interact. Contraindications include active cancer and certain infections, necessitating careful assessment before surgical intervention. Women with a prior cancer history require thorough screening to ensure the tissue is free of malignancy.

Dosage

As ovarian tissue is a biological material rather than a supplement, 'dosage' is more about the surgical handling than a specified dose. Optimal transplant sizes typically range from 1-2 cm in length and width. Time considerations for performing the transplantation depend on the medical circumstances and fertility aspirations of the patient. Proper preservation methods, such as vitrification, are essential to maintain tissue viability. Further, there are no defined upper limits for safety; concerns mainly revolve around the surgical procedure and the individual's health status rather than a dose or quantity of tissue.

FAQs

How long does the procedure take?

The procedure, involving both harvesting and transplantation of ovarian tissue, can take several hours.

What are the chances of success?

Success rates vary but are typically high for hormone restoration and moderate for achieving pregnancy.

Are there any long-term risks?

Long-term risks are minimal, mainly involving tissue rejection and surgical complications.

Is the procedure safe for women with cancer?

Yes, with careful screening to ensure the tissue is free from cancer.

What can I expect post-transplantation?

Patients may expect restoration of hormonal function and potential fertility, but pregnancy is not guaranteed.

Research Sources

  • https://www.scielo.br/j/ar/a/hG4WmLxn9bb89Y7XvdV88Kp/ – This systematic review analyzes outcomes from ovarian tissue transplantation (OTT), highlighting significant restorative effects on ovarian function with increased estrogen and decreased FSH levels post-transplantation.
  • https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.918899/full – This meta-analysis evaluates various vitrification processes for ovarian tissue, examining their impact on follicular viability and morphology, and demonstrates the importance of vitrification techniques.
  • https://pubmed.ncbi.nlm.nih.gov/37211980/ – This article discusses the broader context of infertility treatment, emphasizing the well-studied protocols for ovarian tissue and contrasting them with less standardized supplement ingredients.
  • https://www.animal-reproduction.org/article/10.1590/1984-3143-AR2023-0065/pdf/animreprod-20-3-e20230065.pdf – This study provides insights into ovarian tissue cryopreservation methodologies and their implications for fertility restoration, reinforcing the efficacy and safety of these techniques.
  • https://academic.oup.com/humupd/article/28/3/400/6535334 – This review outlines the advances and clinical applications regarding ovarian tissue transplantation, stressing the clinical significance of hormone restoration and successful fertility outcomes.

Supplements Containing Ovarian Tissue

Equi-Fem by Biotics Research Corporation
70

Equi-Fem

Biotics Research Corporation

Score: 70/100
Equi-Fem by Biotics Research Corporation
70

Equi-Fem

Biotics Research Corporation

Score: 70/100
Equi-Fem Iron & Copper Free by Biotics Research Corporation
70

Equi-Fem Iron & Copper Free

Biotics Research Corporation

Score: 70/100
NutriGyn by Karuna
70

NutriGyn

Karuna

Score: 70/100
Raw Multi-Glandular For Women by Swanson Premium Brand
33

Raw Multi-Glandular For Women

Swanson Premium Brand

Score: 33/100
Ovarian Glandular 250 mg by Swanson
23

Ovarian Glandular 250 mg

Swanson

Score: 23/100

Recommended Articles

Top Fertility Supplements for Women in 2025

Top Fertility Supplements for Women in 2025

By 2025, new FDA-approved fertility supplements, emphasizing organic ingredients, have shown significant effectiveness in aiding conception for women in their 30s.

Best Fertility Supplements for PCOS at 35

Best Fertility Supplements for PCOS at 35

Certain supplements, specifically myo-inositol and folic acid, can significantly improve fertility outcomes for women with PCOS, especially after the age of 35.

Top Fertility Supplements for Women in Late 20s

Top Fertility Supplements for Women in Late 20s

Folic acid, vitamin D, and omega-3s are key supplements for women in their late 20s to improve fertility and prepare for pregnancy.